Prevalence and impact of recreational drug use in patients with acute cardiovascular events

ObjectiveWhile recreational drug use is a risk factor for cardiovascular events, its exact prevalence and prognostic impact in patients admitted for these events are not established. We aimed to assess the prevalence of recreational drug use and its association with in-hospital major adverse events...

Full description

Saved in:
Bibliographic Details
Published inHeart (British Cardiac Society) Vol. 109; no. 21; pp. 1608 - 1616
Main Authors Pezel, Théo, Jean-Guillaume Dillinger, Trimaille, Antonin, Delmas, Clément, Piliero, Nicolas, Bouleti, Claire, Pommier, Thibaut, Amine El Ouahidi, Andrieu, Stéphane, Lattuca, Benoit, Vasram, Reza Rossanaly, Fard, Damien, Noirclerc, Nathalie, Bonnet, Guillaume, Goralski, Marc, Meyer Elbaz, Deney, Antoine, Schurtz, Guillaume, Docq, Clemence, Roubille, Francois, Fauvel, Charles, Bochaton, Thomas, Aboyans, Victor, Boccara, Franck, Puymirat, Etienne, Batisse, Anne, Steg, Gabriel, Vicaut, Eric, Henry, Patrick
Format Journal Article
LanguageEnglish
Published London BMJ Publishing Group LTD 01.11.2023
BMJ Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:ObjectiveWhile recreational drug use is a risk factor for cardiovascular events, its exact prevalence and prognostic impact in patients admitted for these events are not established. We aimed to assess the prevalence of recreational drug use and its association with in-hospital major adverse events (MAEs) in patients admitted to intensive cardiac care units (ICCU).MethodsIn the Addiction in Intensive Cardiac Care Units (ADDICT-ICCU) study, systematic screening for recreational drugs was performed by prospective urinary testing all patients admitted to ICCU in 39 French centres from 7 to 22 April 2021. The primary outcome was prevalence of recreational drug detection. In-hospital MAEs were defined by death, resuscitated cardiac arrest, or haemodynamic shock.ResultsOf 1499 consecutive patients (63±15 years, 70% male), 161 (11%) had a positive test for recreational drugs (cannabis 9.1%, opioids 2.1%, cocaine 1.7%, amphetamines 0.7%, 3,4-methylenedioxymethamphetamine (MDMA) 0.6%). Only 57% of these patients declared recreational drug use. Patients who used recreational drugs exhibited a higher MAE rate than others (13% vs 3%, respectively, p<0.001). Recreational drugs were associated with a higher rate of in-hospital MAEs after adjustment for comorbidities (OR 8.84, 95% CI 4.68 to 16.7, p<0.001). After adjustment, cannabis, cocaine, and MDMA, assessed separately, were independently associated with in-hospital MAEs. Multiple drug detection was frequent (28% of positive patients) and associated with an even higher incidence of MAEs (OR 12.7, 95% CI 4.80 to 35.6, p<0.001).ConclusionThe prevalence of recreational drug use in patients hospitalised in ICCU was 11%. Recreational drug detection was independently associated with worse in-hospital outcomes.Clinical trial registrationNCT05063097.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1355-6037
1468-201X
DOI:10.1136/heartjnl-2023-322520